Effect of Rozerem on the Perception of Gastroesophageal Reflux Disease Symptoms in Patients With Chronic Insomnia.

Trial Profile

Effect of Rozerem on the Perception of Gastroesophageal Reflux Disease Symptoms in Patients With Chronic Insomnia.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Feb 2017

At a glance

  • Drugs Ramelteon (Primary)
  • Indications Gastro-oesophageal reflux; Insomnia
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2011 Planned End Date changed from 1 Jun 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
    • 11 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 28 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top